AD
ADVERTISEMENT

Medical Cannabis for Seniors Topic, March 16

March 9, 2019, 1:00 PM HST · Updated March 8, 9:41 AM
4 Comments
×

Medical cannabis researcher and author, Michael Backes returns to Maui for another Lunch & Learn presentation from 1-3 pm, Saturday July 21, at the Leis Family Class Act Restaurant

Michael Backes, researcher and author of Cannabis Pharmacy will explain why more Hawaiʻi seniors are using medical cannabis to manage age-related conditions.

The Lunch & Learn presentation, “Seniors & Medical Cannabis” is slated for 1 to 3 p.m. on Saturday, March 16 at the Leis Family Class Act Restaurant at the University of Hawaiʻi Maui College. Cost is $20 for registration and includes a hot buffet lunch and class materials. Seating is limited and booking is available online.

“Seniors are the fastest growing group of new medical cannabis patients because many have found they can use fewer prescription drugs and many prefer cannabis to conventional painkillers for arthritis and other age-related aches and pains, severe chronic pain, rheumatoid arthritis, glaucoma, cancer, and chemotherapy side effects,” event organizers said.

“When compared with other medications, the side effects of cannabis tend to be very mild which is why more and more physicians are recommending cannabis as a safe alternative to opioids,” said Backes. During the Lunch & Learn lecture, seniors and caregivers will also learn how to find the best cannabis product for their individual situation and how to titrate proper dosing. Backes will also describe smoke-free cannabis products available at state-licensed dispensaries.

SPONSORED VIDEO

The final 30 minutes of the presentation is reserved for audience questions and answers.

The Lunch & Learn presentation is organized by CertiCann. CertiCann helps patients to obtain or renew their Hawaiʻi Medical Cannabis Card (329 card), that provides safe and legal access to therapeutic cannabis products.

Scroll Down to Read 4 Comments

ADVERTISEMENT

Print

Share this Article

Weekly Newsletter

ARTICLE COMMENTS ( 4 )
View Comments